Uncategorized

RF Lafferty Downgrades Brookfield Renewable to Hold, Lowers Price Target to $35

RF Lafferty analyst Jamie Perez downgrades Brookfield Renewable (NYSE:BEP) from Buy to Hold and lowers the price target from $49 to $35.

byBenzinga Newsdesk

May 4, 2021

1 minute read

RF Lafferty analyst Jamie Perez downgrades Brookfield Renewable (NYSE:BEP) from Buy to Hold and lowers the price target from $49 to $35.

Horizon Global Announces Appointment Of John C. Kennedy As Interim President, Chief Executive Officer

By Michael Horton

Today, 3:08 AM

Horizon Global Corporation (NYSE:HZN) (the "Company"), announced today that the Company's Board of Directors (the "Board") appointed John C. Kennedy as Interim President and Chief Executive

HZN

Credit Suisse Maintains Outperform on Hanesbrands, Lowers Price Target to $13

By Benzinga Newsdesk

Today, 3:08 AM

Credit Suisse analyst Michael Binetti maintains Hanesbrands (NYSE:HBI) with a Outperform and lowers the price target from $15 to $13.

HBI

FDA
News

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA PMA Approval Of Scoreflex Scoring Balloon

By Bill Haddad

Today, 3:08 AM

Cardiovascular Systems, Inc. (CSI®) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today,

CSII

(CTAS) – Analyzing Cintas Corporation’s Short Interest

By Benzinga Insights

Today, 3:08 AM

Cintas Corporation's (NASDAQ:CTAS) short percent of float has fallen 5.98% since last its last report. The company recently reported that it has 970.60 thousand shares sold short, which is 1.1% of all regular shares that are available for trading.

CTAS

RF Lafferty Downgrades Brookfield Renewable to Hold, Lowers Price Target to $35

Related Posts

Horizon Global Announces Appointment Of John C. Kennedy As Interim President, Chief Executive Officer

Credit Suisse Maintains Outperform on Hanesbrands, Lowers Price Target to $13

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA PMA Approval Of Scoreflex Scoring Balloon

(CTAS) – Analyzing Cintas Corporation’s Short Interest